Guardant Health Stock Today
| GH Stock | USD 35.61 0.51 1.45% |
Performance13 of 100
| Odds Of DistressLess than 32
|
Guardant Health is trading at 35.61 as of the 30th of November 2024. This is a 1.45 percent increase since the beginning of the trading day. The stock's open price was 35.1. Guardant Health has about a 32 percent probability of financial distress in the next few years of operation but had a somewhat good performance during the last 90 days. Equity ratings for Guardant Health are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 9th of June 2023 and ending today, the 30th of November 2024. Click here to learn more.
Business Domain Health Care Equipment & Services | IPO Date 4th of October 2018 | Category Healthcare | Classification Health Care |
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company was incorporated in 2011 and is headquartered in Redwood City, California. Guardant Health operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. The company has 123.56 M outstanding shares of which 9.39 M shares are currently sold short in the market by investors with about 4.56 days to cover all shorted shares. More on Guardant Health
Moving together with Guardant Stock
Moving against Guardant Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Guardant Stock Highlights
ESG Sustainability
Environmental | Governance | Social |
| CoCEO CoFounder | Helmy Eltoukhy | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Thematic Idea | Healthcare (View all Themes) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Health Care Providers & Services, Health Care Equipment & Services, Health Care, NASDAQ Biotechnology, NASDAQ Composite, Healthcare, Health Care, Health Care Providers & Services, Diagnostics & Research, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt LevelsGuardant Health can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Guardant Health's financial leverage. It provides some insight into what part of Guardant Health's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Guardant Health (GH) is traded on NASDAQ Exchange in USA. It is located in 3100 Hanover Street, Palo Alto, CA, United States, 94304 and employs 1,768 people. Guardant Health is listed under Health Care Providers & Services category by Fama And French industry classification. The company currently falls under 'Mid-Cap' category with a market capitalization of 4.4 B. Guardant Health is active under Health Care Providers & Services sector as part of Health Care industry. The entity has 123.56 M outstanding shares of which 9.39 M shares are currently sold short in the market by investors with about 4.56 days to cover all shorted shares.
Guardant Health reports about 853.69 M in cash with (324.98 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 8.35.
Check Guardant Health Probability Of Bankruptcy
Ownership AllocationThe majority of Guardant Health outstanding shares are owned by outside corporations. These institutional investors are usually referred to as non-private investors looking to purchase positions in Guardant Health to benefit from reduced commissions. Consequently, third-party entities are subject to a different set of regulations than regular investors in Guardant Health. Please pay attention to any change in the institutional holdings of Guardant Health as this could imply that something significant has changed or is about to change at the company.
Check Guardant Ownership Details
Guardant Stock Institutional Holders
| Instituion | Recorded On | Shares | |
| Geode Capital Management, Llc | 2024-09-30 | 2.8 M | |
| Parkwood Llc | 2024-06-30 | 2.8 M | |
| State Street Corp | 2024-06-30 | 2.8 M | |
| Fuller & Thaler Asset Management Inc | 2024-09-30 | 2.2 M | |
| Millennium Management Llc | 2024-06-30 | 2.1 M | |
| Temasek Holdings Ltd. | 2024-09-30 | 2.1 M | |
| Fidelity International Ltd | 2024-06-30 | 2.1 M | |
| Ark Investment Management Llc | 2024-09-30 | 1.5 M | |
| Fmr Inc | 2024-09-30 | 1.5 M | |
| Vanguard Group Inc | 2024-09-30 | 11.7 M | |
| Blackrock Inc | 2024-06-30 | 11.2 M |
Guardant Health Historical Income Statement
Guardant Stock Against Markets
Guardant Health Corporate Management
| Jennifer Higgins | Senior Affairs | Profile | |
| Stephen Murphy | Senior Marketing | Profile | |
| John Saia | Chief Secretary | Profile | |
| Christopher Freeman | Chief Officer | Profile | |
| John JD | Chief Secretary | Profile | |
| Zarak Khurshid | Vice Relations | Profile |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Guardant Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. For more detail on how to invest in Guardant Stock please use our How to Invest in Guardant Health guide.You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Guardant Health. If investors know Guardant will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Guardant Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (4.28) | Revenue Per Share 5.7 | Quarterly Revenue Growth 0.339 | Return On Assets (0.16) | Return On Equity (6.09) |
The market value of Guardant Health is measured differently than its book value, which is the value of Guardant that is recorded on the company's balance sheet. Investors also form their own opinion of Guardant Health's value that differs from its market value or its book value, called intrinsic value, which is Guardant Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Guardant Health's market value can be influenced by many factors that don't directly affect Guardant Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Guardant Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Guardant Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Guardant Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.